| The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT. | |
| | |
MedLine Citation:
|
PMID: 19602435 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The new SeDeM Diagram expert system was used to analyze the suitability of 43 excipients for direct compression with disintegrant properties from eight chemical families. The SeDeM Diagram expert system is a new method for use in tablet preformulation and formulation studies. It provides the profile of a substance in powder form in terms of its suitability for direct compression. This study, which was based on the current concept of "Quality by Design ICH Q8", evaluated the pharmacotechnical properties of disintegrants in powder form and selected the candidates that were most suitable for direct compression and their use in formulation of orally disintegrating tablets (ODT). To achieve this, each disintegrant and its chemical families were individually analyzed. It was concluded that nine disintegrants had an SeDeM value with the index of good compression (IGC) over 5. Most of these disintegrants were from the microcellulose family. Other disintegrants had indexes that were close to 5. It is assumed that these excipients can be used in direct compression, when they are added to other excipients. |
| | |
Authors:
|
Johnny Edward Aguilar-D??az; Encarnaci??n Garc??a-Montoya; Pilar P??rez-Lozano; Jos?? Mar??a Su??e-Negre; Montserrat Mi??arro; Jos?? Ram??n Tic?? |
Related Documents
:
|
7196135 - A model for the analysis of mate selection in the marriages of twins: application to da... 11523705 - Multivariate models of mixed assortment: phenotypic assortment and social homogamy for ... 17401765 - Neonatal circumcision model and competency evaluation for family medicine residents. 17205325 - Heritability and shared environment estimates for myopia and associated ocular biometri... 7189205 - Global asymptotic stability for a vector disease model with spatial spread. 11858635 - Beware of q2! |
Publication Detail:
|
Type: Journal Article Date: 2009-07-12 |
Journal Detail:
|
Title: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft f??r Pharmazeutische Verfahrenstechnik e.V Volume: 73 ISSN: 1873-3441 ISO Abbreviation: Eur J Pharm Biopharm Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2009-11-05 Completed Date: 2010-01-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9109778 Medline TA: Eur J Pharm Biopharm Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 414-23 Citation Subset: IM |
Affiliation:
|
Pharmacy and Pharmaceutical Technology Department, University of Barcelona, Barcelona, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Cellulose / chemistry Chemistry, Pharmaceutical / methods* Excipients / chemistry* Powders Tablets |
| Chemical | |
Reg. No./Substance:
|
0/Excipients; 0/Powders; 0/Tablets; 9004-34-6/Cellulose |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antiproliferative and cytotoxic effects of sodium selenite in human colon cancer cells.
Next Document: Magnetic resonance imaging of tablet dissolution.